This investment fund aims to mirror the performance, prior to fees and expenses, of a specific benchmark index. This index is designed to track companies worldwide that are poised to generate revenue from addressing or serving the obese population. These companies span various sectors, including biotechnology, pharmaceuticals, healthcare, and medical device firms primarily focused on obesity and its related health conditions.